Therapeutics: E selectin (SELE; CD62E); CXC chemokine receptor 4 (CXCR4; NPY3R)

Cancer

INDICATION: Breast cancer

Patient sample and mouse studies suggest inhibiting SELE and/or CXCR4 could help prevent bone metastases of breast

Read the full 199 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE